Oscar Health Inc. (OSCR) Tops Q2 EPS by 15c

Oscar Health Inc. (NYSE: OSCR) reported Q2 EPS of ($0.07), $0.15 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.38 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Barclays Upgrades Oscar Health Inc (OSCR) to Overweight, 'we see a visible path to an undemanding 13–15x P/E valuation'
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c
• RH (RH) Tops Q1 EPS by 12c